| 134.8 1.84 (1.38%) | 08-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 163.01 |
1-year : | 190.4 |
| Resists | First : | 139.57 |
Second : | 163.01 |
| Pivot price | 134.08 |
|||
| Supports | First : | 132.09 |
Second : | 127.46 |
| MAs | MA(5) : | 132.83 |
MA(20) : | 134.25 |
| MA(100) : | 124.67 |
MA(250) : | 126.03  |
|
| MACD | MACD : | 1.1 |
Signal : | 1.6 |
| %K %D | K(14,3) : | 41.6 |
D(3) : | 32.3 |
| RSI | RSI(14): 59.2 |
|||
| 52-week | High : | 145.81 | Low : | 102.06 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ATR ] has closed below upper band by 39.7%. Bollinger Bands are 36.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 135.33 - 135.87 | 135.87 - 136.44 |
| Low: | 131.22 - 131.78 | 131.78 - 132.37 |
| Close: | 133.87 - 134.85 | 134.85 - 135.87 |
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Sat, 22 Aug 2026
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report? - Eastern Progress
Thu, 20 Aug 2026
Aurora Investment Counsel Acquires New Stake in AptarGroup, Inc. $ATR - MarketBeat
Tue, 18 Aug 2026
Nuance Investments LLC Makes New Investment in AptarGroup, Inc. $ATR - MarketBeat
Tue, 11 Aug 2026
AptarGroup, Inc. $ATR Shares Acquired by Bank of America Corp DE - MarketBeat
Mon, 10 Aug 2026
AptarGroup, Inc. (ATR) Stock Analysis: 25.64% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Mon, 03 Aug 2026
Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 64 (M) |
| Shares Float | 63 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 96.9 (%) |
| Shares Short | 1,840 (K) |
| Shares Short P.Month | 2,280 (K) |
| EPS | 5.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 41.33 |
| Profit Margin | 9.2 % |
| Operating Margin | 12.4 % |
| Return on Assets (ttm) | 6.1 % |
| Return on Equity (ttm) | 13.4 % |
| Qtrly Rev. Growth | 6.3 % |
| Gross Profit (p.s.) | 22.33 |
| Sales Per Share | 61.81 |
| EBITDA (p.s.) | 12.55 |
| Qtrly Earnings Growth | -18.7 % |
| Operating Cash Flow | 583 (M) |
| Levered Free Cash Flow | 266 (M) |
| PE Ratio | 24.33 |
| PEG Ratio | 2.4 |
| Price to Book value | 3.26 |
| Price to Sales | 2.18 |
| Price to Cash Flow | 14.68 |
| Dividend | 0.47 |
| Forward Dividend | 0 |
| Dividend Yield | 0.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|